Rocky88888888888

$ABEO Next Target PTs .60-1 and higher

Long
NASDAQ:ABEO   Abeona Therapeutics Inc
Abeona Therapeutics Inc ., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc . in June 2015. Abeona Therapeutics Inc . was founded in 1974 and is headquartered in New York, New York.

Hi Discord❤️
✔️https://discord.gg/yXNVTcVWHR
✔️https://linktr.ee/rocky88888888888_discord